- This event has passed.
CBHL Member Roundtable | Supporting the Uptake of Behavioral Health Apps
February 27 @ 11:00 am – 12:00 pm MST
Have you considered the possibility of integrating behavioral health apps or new technologies into your services? Do you feel stuck by how to choose the right technology, or how to implement successfully?
Join us for an engaging discussion based on the insights shared in our November 2023 webinar, Revolutionizing Behavioral Health: The Role of Behavioral Health Apps in Addressing the Workforce Crisis, which delved into the potential of behavioral health apps as a transformative technology supporting both mental and physical wellbeing. The escalating demand for behavioral health services coupled with challenges in the workforce creates a compelling reason to take a closer look at forward-thinking solutions.
In this member roundtable, panelists will rejoin us to explore how to successfully integrate behavioral health apps and technology into existing practices. We will discuss challenges faced by organizations in determining how to select the right technology, considerations for how to implement as a complement to existing services, and talk about what additional support members might need to feel more informed and better equipped to implement successfully.
When: February 27, 2024 | 10am-11am PT / 11am-12pm MT / 12pm-1pm CT / 1pm-2pm ET
Dr. David R. Gastfriend M.D., DFASAM | Addiction Psychiatrist at Harvard Medical School
Dr. Garrett E. Moran, Ph.D. | Principal Investigator for the Academy for Integrating Behavioral Health and Primary Care
Harris Eyre, M.D., Ph.D. | Kooth Digital Health
Dr. Gastfriend is an addiction psychiatrist. At Harvard Medical School, he directed addiction research at Massachusetts General Hospital and was an investigator in the NIDA Cocaine Collaborative Study, NIAAA’s COMBINE Study and NIDA’s Clinical Trials Network. As Vice President at Alkermes, Inc., he directed scientific publications on Vivitrol in clinical, criminal justice and health economics research.
His research led most states to endorse the American Society of Addiction Medicine (ASAM) Criteria. His 150 scientific publications include the books The ASAM Criteria and Addiction Treatment Matching. His ASAM CONTINUUM – The ASAM Criteria Decision Engine ® and ASAM’s CO-Triage ® tools are being adopted nationwide.
In 2016, he co-founded DynamiCare Health, a nationally-scalable technology for Contingency Management and predictive analytics, winning awards from Harvard Business School, the Commonwealth of Massachusetts, the Governor of Ohio, and the New York Times. He has consulted to governments in Belgium, China, Iceland, Israel, Norway, Russia and the U.S.
Garrett E. Moran, Ph.D., serves as the the Principal Investigator for the Academy for Integrating Behavioral Health and Primary Care, a program sponsored by the federal Agency for Healthcare Research and Quality (AHRQ), and served as Project Director of the Academy from 2010 until 2018. He is deeply committed to advancing holistic, person-centered health care. Dr. Moran retired in 2021 from his role as the Associate Director of Services and Policy Innovation in the Rockefeller Neurosciences Institute, and Professor in the School of Public Health and the Department of Behavioral Medicine and Psychiatry at West Virginia University (WVU). Before coming to WVU he was a Vice President and Associate Director at Westat where he worked for 29 years.
Dr. Moran has more than 50 years of experience in public policy, program evaluation, research, and management. His career has included key leadership roles on projects for the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Office of the Assistant Secretary for Planning and Evaluation (ASPE), as well as consulting roles with states working on health reform and care
integration. His major areas of substantive expertise include integrated healthcare delivery, health care financing, health information technology, and program evaluation. Dr. Moran directed the consultant support and writing contract for the President’s New Freedom Commission on Mental Health in the early 2000s, and subsequently served as an Advisor and Consultant to the States of Maryland and Ohio as they developed mental health transformation plans.
From 1993 to 1996, Dr. Moran served as behavioral health commissioner in the Department of Health and Human Resources for the State of West Virginia. In this role, he guided public policy related to people with mental or substance use disorders, developmental disabilities, and older adults. Dr. Moran is also a clinical psychologist, whose early career included several years of direct clinical work with people with behavioral health disorders.
Dr. Eyre is a mental and brain health-focused systems executive. He has trained in clinical psychiatry, neuroscience, health administration, health entrepreneurship, and public policy. With these experiences, he’s looking to impact mental and brain health at scale.
He was co-founder and chief medical officer of a precision mental health company. In this capacity, he worked in teams towards many industry firsts. That is, the first depression pharmacogenetic tool to be used by a large integrated delivery network, as well as in a large primary care network. Noted by the US VA as the most promising tool for depression, he co-led the securing of philanthropic funding for the first independently funded multicenter RCT for pharmacogenetics in severe mood disorders.
His other key positions are Senior Fellow at Meadows Mental Health Policy Institute and Lead at the Brain Capital Alliance. He advises the HEKA Fund, the Euro-Mediterranean Economists Association, Kooth, and is a member of the Champion’s Cabinet of the Davos Alzheimer’s Collaborative and The University of Sydney’s Mental Wealth Initiative.
He is an alumnus of the Forbes 30 Under 30 and the Fulbright Scholar program, and an awardee of the EB1A Green Card, an honor typically reserved for Nobel and Pulitzer prize winners. He has authored 190+ papers with 1000s of coauthors in journals such as World Psychiatry, and Lancet Psychiatry, and was the lead editor of the book ‘Convergence Mental Health’ (Oxford Press).
Dr Eyre maintains adjunct positions with Baylor College of Medicine, The University of Texas Health Sciences Center at Houston (UTHealth), Houston Methodist, and Deakin University’s IMPACT (Institute for Mental and Physical Health and Clinical Translation).